about
Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic painRedox Imbalance and Viral Infections in Neurodegenerative DiseasesCrosstalk between Long Noncoding RNAs and MicroRNAs in Health and DiseaseIndividuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyAnti-Viral Properties of Amyloid-β Peptides.Polymicrobial Infections In Brain Tissue From Alzheimer's Disease PatientsAging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's DiseaseDifferent Brain Regions are Infected with Fungi in Alzheimer's Disease.Microbes and Alzheimer's Disease.MAPT as a predisposing gene for sporadic amyotrophic lateral sclerosis in the Chinese Han populationMast cells and neuroinflammation.Oxidative stress enhances neurodegeneration markers induced by herpes simplex virus type 1 infection in human neuroblastoma cellsAtherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature3-D imaging and analysis of neurons infected in vivo with Toxoplasma gondiiHistoric evidence to support a causal relationship between spirochetal infections and Alzheimer's disease.Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis.Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's DiseaseExposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril.Behavioral and omics analyses study on potential involvement of dipeptide balenine through supplementation in diet of senescence-accelerated mouse prone 8.Herpes Simplex Virus-Type1 (HSV-1) Impairs DNA Repair in Cortical Neurons.Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey.Liver granulomatosis: a case of Chlamydophila pneumoniae infection.Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.Inflammation in neurodegenerative diseases--an update.Amyotrophic lateral sclerosis: a long preclinical period?The Role of PICALM in Alzheimer's Disease.The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system.Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit.P. acnes-Driven Disease Pathology: Current Knowledge and Future Directions.Metallothioneins in Prion- and Amyloid-Related Diseases.Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.An update on potential therapeutic strategies for Parkinson's disease based on pathogenic mechanisms.Synaptoimmunology - roles in health and disease.HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders.Cerebrospinal Fluid from Alzheimer's Disease Patients Contains Fungal Proteins and DNA.Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): implications for Alzheimer's disease pathogenesis.Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.Host genetic background influences diverse neurological responses to viral infection in mice.
P2860
Q21284848-FE15175A-0D19-4563-AC58-4FFE8BCBDCB3Q26750630-47385AF4-4011-4702-9C4E-770A7202AEE3Q26765464-89CFE828-9175-41D5-AE68-581F97962B1CQ26775404-247377B5-4ED4-4AD6-95E8-FC5CFD5B55B5Q30390299-1A646C9E-B21A-421A-AF10-E9A3E11B8724Q33911848-AA104480-1280-4334-9665-1BF8495EAEECQ33920647-B3AE93DC-0D87-4294-8F45-B4D24B82CB1AQ34045152-75900433-8E32-401C-AEA0-DCC1D1ACE65BQ34046427-3857C0A5-678A-4B34-9EA2-87CBFD6EA653Q34153586-AB7AAE0C-093C-486D-BA5C-4FEF136449E1Q34810678-F1BCDDAC-05BE-4136-9B5C-82882A3F5AC8Q35016835-A3BECE87-DBEC-499D-93E0-37477158D7C2Q35127516-D8AC057E-68E6-436F-9D3D-954F1B5102C0Q35185057-83915463-8111-4BF6-A2C6-8A5B8835D058Q35442946-DB612A4A-6620-45E6-8F74-F3BFCBE015B0Q35451557-2734D636-DF67-45D2-959D-72E3C0821C6DQ36950856-FE18B95D-42DA-427F-B475-E06B739A853FQ36956118-E7E03A80-3C0F-46D9-A23F-C44D39196FAFQ37151315-7D7CFC45-AC9F-4B48-B63D-BABCC0B06FFCQ37270852-5FCB87A4-7F17-461E-982A-8FA28FFA5F98Q37345316-93FC5362-6D46-4866-BD67-26B99A4035DEQ37604470-0AAF1740-D585-4688-AEC5-9AE92556739EQ37843664-AB8D14B6-CF46-4AE6-A972-406AD5DAE228Q38099065-0CAA5277-EBC2-43B9-A120-09266B6367C4Q38170472-467CEE55-DD83-4003-A88B-201026768520Q38197553-5618456C-2FB8-4261-807B-280C9BA4830AQ38245888-07CB9FED-455D-498B-8566-8F20679A0DAFQ38258061-9BBAEE5C-89E9-4D74-B74A-5E5550F8E023Q38667942-7897AED6-A013-4984-BFFC-3CC55DA6EBF6Q38693771-BB32B3A0-606D-4BB0-9074-BD1B142BC0F0Q38738270-23153E1E-4BFE-45E9-8C80-DF81F9376D5DQ38753411-1631B70A-8B8E-42D1-A487-7DC7382E6A74Q38797410-4F16891C-AB7A-4DFA-9F01-79059E3A0163Q38823785-0C069B41-38BF-4B12-962B-85C19EAF49B8Q39388657-66AEB681-A39A-467E-90D6-225E1D650274Q40058240-8BBE53D2-B85F-4519-B9D3-18AA13964B78Q40984218-BC03D8F9-773C-44C6-BBD4-7858F5BE70A9Q40997303-CADB3B1E-853B-4480-9EB0-8BBBDC58FEDEQ41922958-DFFE466D-6CDC-4972-BDE1-592225D1A870Q41931819-22DD92C1-3209-45B6-ABB8-90150CD7CF82
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infectious agents and neurodegeneration.
@en
Infectious agents and neurodegeneration.
@nl
type
label
Infectious agents and neurodegeneration.
@en
Infectious agents and neurodegeneration.
@nl
prefLabel
Infectious agents and neurodegeneration.
@en
Infectious agents and neurodegeneration.
@nl
P2860
P50
P1476
Infectious agents and neurodegeneration.
@en
P2093
Enrico Garaci
P2860
P2888
P304
P356
10.1007/S12035-012-8320-7
P50
P577
2012-08-17T00:00:00Z